3 Stocks I Saw on T...
Health Care: Drugs
Celldex Therapeutics Inc. (CLDX: NASDAQ)
$4.08 0.09 | 2.26%
06/04/12 - 04:00 PM ET
Company Income Statement
| Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | |
| Sales | 9.26M | 46.79M | 15.18M | 7.46M |
| Cost of Sales | 6.85M | 9.37M | 5.81M | -2.18M |
| Gross Operating Profit | 2.41M | 37.42M | 9.37M | 9.63M |
| Selling, General, and Administrative Expenses | 9.24M | 10.43M | 17.12M | 14.75M |
| Research & Development | 32.44M | 27.65M | 26.17M | 26.35M |
| Operating Income before D & A (EBITDA) | -39.27M | -658.00K | -33.92M | -31.46M |
| Depreciation & Amortization | 4.18M | 5.85M | 3.53M | 2.54M |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income - Net | 446.00K | 5.31M | 852.00K | 1.26M |
| Special Income / Charges | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Income Before Interest Expenses (EBIT) | -43.00M | -1.20M | -36.60M | -47.50M |
| Interest Expense | 1.80M | 1.34M | 452.00K | 0.00 |
| Pre-Tax Income | -44.80M | -2.53M | -37.05M | -47.50M |
| Income Taxes | 0.00 | 0.00 | -529.00K | 0.00 |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Continuing Operations | -44.80M | -2.53M | -36.52M | -47.50M |
| Net Income From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Total Operations | -44.80M | -2.53M | -36.52M | -47.50M |
| Extraordinary Income/Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Cum. Effect of Acct. Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Tax Loss Carryforward | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Net Income | -44.80M | -2.53M | -36.52M | -47.50M |
| Normalized Income (Net Income From Continuing Operations, Ex. Special Income / Charge) |
-44.80M | -2.53M | -36.52M | -32.74M |
| Preferred Dividends | ||||
|---|---|---|---|---|
| Net Income Available To Common | -44.80M | -2.53M | -36.52M | -47.50M |
| Basic EPS from Continuing Ops. | -1.13 | -0.08 | -1.84 | -3.34 |
| Basic EPS from Discontinued Ops. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Total Operations | -1.13 | -0.08 | -1.84 | -3.34 |
| Basic EPS from Extraordinary Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Tax Loss Carryf'd. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Other Gains (Losses) | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS, Total | -1.13 | -0.08 | -1.84 | -3.34 |
| Basic Normalized Net Income/Share | -1.13 | -0.08 | -1.84 | -2.30 |
| EPS fr Continuing Ops. | -1.13 | -0.08 | -1.84 | -3.34 |
| EPS fr Discontinued Ops | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Total Ops. | -1.13 | -0.08 | -1.84 | -3.34 |
| EPS fr Extraord. Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Tax Loss Carfd. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Other Gains (L) | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS, Total | -1.13 | -0.08 | -1.84 | -3.34 |
| Diluted Normalized Net Inc/Shr (Net Income From Continuing Operations, Ex. Special Income / Charge) |
-1.13 | -0.08 | -1.84 | -2.30 |
| Dividends Paid per Share | 0.00 | 0.00 | 0.00 | 0.00 |
Portfolios with CLDX
- Portfolio NameUser Type
- Userbio
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- Contributor7 Cancer Drug Stocks to Kno...
- ContributorStocks Under-$10 Moving Hig...
- Contributor10 Cheap Biotech Stocks Tha...
- User3rdwavemedia Portfolio 1
- UserSUPRATRADE 7 Top Stocks for...
- UserASCO 2010
- UserSolstock
Latest CLDX Headlines from TheStreet
- ASCO '12 Stocks: Winners and Losers 06.04.12 | 06:06 am
- Biotech Stock Mailbag: ASCO, Celldex, Obesity Drug Game-Changer 05.25.12 | 05:05 am
- Celldex Targeted Drug Shrinks Breast Cancer 05.23.12 | 04:05 pm
- The Next Big Thing In Biotech: Celldex
05.18.12 | 07:05 am - 7 Stocks Under $10 Making Big Moves 05.17.12 | 12:05 pm
- Biotech Stock Live Chat Recap: ASCO & Obesity 05.17.12 | 11:05 am
- Celldex Screw-Up Nixes ASCO Data Slot 05.01.12 | 07:05 am
- Biotech Stock Mailbag: All You Need to Know About Hep C Drugs 04.13.12 | 05:04 am
- 8 Stocks Under $10 Moving Higher 03.20.12 | 12:03 pm
- Biotech Stock Chat: Recap 03.15.12 | 11:03 am
Press Releases for CLDX
- Celldex Therapeutics To Present At The Jefferies 2012 Global Healthcare Conference - Business Wire 05.31.12 | 09:05 am
- Celldex’s CDX-011 Demonstrates High Response Rates In Patients With Metastatic Breast Cancer Expressing Elevated Levels Of GPNMB And In Triple Negative Disease - Business Wire 05.23.12 | 04:05 pm
- Celldex Therapeutics To Host Call To Announce Topline Results From The EMERGE Study In Advanced Breast Cancer - Business Wire 05.18.12 | 10:05 am
- Celldex Reports First Quarter 2012 Financial Results - Business Wire 05.03.12 | 08:05 am
- Celldex Announces Plans To Release Topline Results From The EMERGE Study In Advanced Breast Cancer - Business Wire 05.01.12 | 07:05 am
- Celldex Announces Exercise Of Over-Allotment Option - Business Wire 03.14.12 | 05:03 pm
- Celldex Reports Fourth Quarter And Fiscal 2011 Financial Results - Business Wire 03.07.12 | 07:03 am
- Celldex Therapeutics To Host Corporate 2011 Year-End And 2012 Objectives Update Call - Business Wire 02.29.12 | 03:02 pm
- Celldex Therapeutics To Present At The Citi 2012 Global Health Care Conference - Business Wire 02.24.12 | 10:02 am
- Celldex Prices Public Offering Of Common Stock - Business Wire 02.24.12 | 09:02 am
Partner Headlines for CLDX
- IsoRay: A Potential Small-Cap Bio-Pharma Multi-Bagger - Seeking Alpha 05.29.12 | 09:05 am
- Pre-Market Most Active for May 24, 2012 : BAC, PPL, EMC, NTAP, HPQ, MTGE, CLDX, TS, FB, MT, QQQ, VOD - NASDAQ 05.24.12 | 12:05 pm
- Analyst Insights: Celldex, InterMune, American Tower, Thermo Fisher, Jiayuan.com May 24th - Wall St. Cheat Sheet 05.24.12 | 11:05 am
- After Hours Most Active for May 23, 2012 : NTAP, HPQ, BAC, BLK, IFSIA, QQQ, F, CLDX, KMI, PFE, ERIC, FB - NASDAQ 05.23.12 | 08:05 pm
- Breast Cancer Immunotherapy: A New Hope In The Fight - Seeking Alpha 03.09.12 | 08:03 am
- Notable Put Options Activity in Celldex Therapeutics - Benzinga 03.06.12 | 01:03 pm
- Notable Put Options Activity in Celldex Therapeutics - Benzinga 02.27.12 | 01:02 pm
- Immunocellular Again Pushing To $2 - Seeking Alpha 02.15.12 | 09:02 am
- 10 Biotech Stocks With 100% Upside In 2012: Part One - Seeking Alpha 02.09.12 | 10:02 am
- Biotech Stocks To Watch In 2012 - Seeking Alpha 02.06.12 | 09:02 am
